SBMFF — Sino Biopharmaceutical Limited/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 1604982 ·
Last close
$0.69
Market Cap
$12.38B
52W High
$1.08
52W Low
$0.59
ADV30
1,233
Next earnings
2026-08-19
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 76,009,821,000 | 12,180,729,000 | 33,923,894,000 |
| Jun 2025 | — | — | — | — | 74,894,406,000 | 11,103,702,000 | 29,116,691,000 |
| Dec 2024 | — | — | — | — | 65,408,069,000 | 9,569,584,000 | 22,633,999,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$24,953,344,000
Inventory
$2,256,663,000
Receivables
—
ST Investments
$10,780,739,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$33,704,073,216
EBITDA
$10,410,426,368
Free Cash Flow
$6,601,288,704
Enterprise Value
$15,759,328,256
Total Cash
$27,577,458,688
Total Debt
$17,171,440,640
Shares Out
17,818,952,537
Trailing EPS
$0.02
Book Value
$0.25
ROE
14.1%
ROA
7.5%
Div Yield
2.19%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 31,834,488,000 | 6,899,933,000 | 2,343,348,000 | 76,009,821,000 | 33,923,894,000 | 30,670,958,000 | 9,291,821,000 |
| Dec 2024 | 28,866,159,000 | 6,334,492,000 | 3,499,834,000 | 65,408,069,000 | 22,633,999,000 | 31,960,789,000 | 6,615,120,000 |
| Dec 2023 | 26,199,409,000 | 6,086,401,000 | 2,331,939,000 | 63,604,819,000 | 25,434,866,000 | 30,474,469,000 | 6,065,734,000 |
| Dec 2022 | 26,026,164,000 | 5,479,804,000 | 2,543,570,000 | 64,064,284,000 | 26,120,736,000 | 29,747,035,000 | 6,265,155,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| YRAIF | YARA INTERNATIONAL ASA | $12.47B | $48.96 | — |
| DQJCF | Don Quijote Holdings Co Ltd | $12.56B | $4.20 | — |
| NVMI | NOVA LTD. | $12.60B | $396.12 | — |
| HAS | HASBRO, INC. | $12.63B | $89.54 | — |
| SHLAF | Schindler Holding AG/ADR | $12.77B | $320.00 | — |
News headlines (Yahoo Finance, 1h cache)
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
2026-08-19 11:45 · Yahoo
What Do Recent Swings and Cash Flow Growth Mean for Sino Biopharm’s 2025 Value?
2025-10-19 22:08 · Yahoo
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
2025-10-16 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.